siRNA, Anti-NKAPD1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT41610WQ-2OMe)

The product SIRGT41610WQ-2OMe is a type of small interfering RNA (siRNA) that targets NKAPD1 gene and regulates the expression of gene. The siRNA interferes with the expression of NKAPD1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001082969.1
Alternative Names C11orf57
Related Diseases Cancer
Purification HPLC
Target Gene
Gene ID 55216
Uniprot ID Q6ZUT1
Sub Cat Target Species Modification Scale  
SIRGT42610WQ-2F NKAPD1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT43610WQ-2MOE NKAPD1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT44610WQ-LNA NKAPD1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT41610WQ-RB NKAPD1 Human Ribo-modified Inquiry
SIRGT42610WQ-BB NKAPD1 Human Backbone-modified Inquiry

Related Products